The drug-induced hepatotoxicity
药物引起的肝毒性
基本信息
- 批准号:09470491
- 负责人:
- 金额:$ 5.95万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The drug-induced hepatotoxicity was studied on the oxidative stress and reactive metabolites, using liver microsomes, isolated hepatocytes, primary cultured hepatocytes and liver tissues.The chemiluminescence was used to investigate the drug-induced oxidative stress. The chemiluminescence-HPLC system was set up and we tried to measure the lipid peroxides produced during the drug metabolism. And phosphatidyl choline hydroperoxide (PCOOH) was detected in the rat liver microsome and isolated hepatocyte suspension incubated with ethacrynic acid. It was observed that PCOOH was produced earlier than the thiobarbituric acid reactive substances (TBARS) formation. The ultraweak chemiluminescence was shown to be emitted directly from the liver microsomes and isolated hepatocytes incubated with ethacrynic acid. This was accompanied by the LDH release from the isolated hepatocytes. Further, we set up the organ chemiluminescence system and succeeded in detecting the ultraweak chemiluminescence emitted from the rat liver perfused with ethacrynic acid. This result substantiated the ethacrynic acid-induced oxidative stress in the liver. These results obtained from the chemiluminescence detection systems were found to be related closely with the alteration in glutathione. Thus the oxidative stress due to the drug metabolism was shown to be detectable by the chemiluminescence system with high sensitivity and specificity.Dihydralazine is known to cause the immunohepatitis and CYP1A2 is reported as a target protein of its reactive metabolite. In addition, CYP3A4 was found to be its target protein in rat and human liver microsomes. The imipramine- and mianserin-induced hepatotoxicity was shown to be closely related with their reactive metabolites. The diphenylamine structure was found to play an important role in the nonsteroidal anti-inflammatory drug-induced hepatotoxicity. The NSAIDs with diphenylamine structure were shown to be uncouplers of oxidative phosphorylation.
采用肝微粒体、分离肝细胞、原代培养肝细胞和肝组织,从氧化应激和反应性代谢产物方面研究药物引起的肝毒性。采用化学发光法研究药物引起的氧化应激。建立了化学发光-HPLC系统,尝试测定药物代谢过程中产生的脂质过氧化物。在与利尿酸孵育的大鼠肝微粒体和分离的肝细胞悬液中检测到磷脂酰胆碱过氧化氢(PCOOH)。据观察,PCOOH 的产生早于硫代巴比妥酸反应物质 (TBARS) 的形成。超弱化学发光被证明是直接从与利尿酸一起孵育的肝微粒体和分离的肝细胞中发射的。这伴随着分离的肝细胞中 LDH 的释放。此外,我们建立了器官化学发光系统,并成功检测到了灌注利尿酸的大鼠肝脏发出的超弱化学发光。这一结果证实了利尿酸诱导的肝脏氧化应激。化学发光检测系统获得的这些结果被发现与谷胱甘肽的变化密切相关。因此,化学发光系统可以高灵敏度和特异性地检测药物代谢引起的氧化应激。已知二肼苯达嗪会引起免疫性肝炎,据报道CYP1A2是其反应性代谢物的靶蛋白。此外,在大鼠和人肝微粒体中发现CYP3A4是其靶蛋白。丙咪嗪和米安舍林引起的肝毒性与其活性代谢物密切相关。研究发现二苯胺结构在非甾体抗炎药引起的肝毒性中发挥重要作用。具有二苯胺结构的非甾体抗炎药被证明是氧化磷酸化的解偶联剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hiroyuki Yokoyama: "Glutathione disulfide formation during naproxen metabolism in the isolated rat hepatocytes"Research Communications in Molecular Pathology and Pharmacology. 99,2. 143-154 (1998)
Hiroyuki Yokoyama:“在离体大鼠肝细胞中萘普生代谢过程中谷胱甘肽二硫化物的形成”分子病理学和药理学研究通讯。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yasuhiro Masubuchi: "Dihydralazine-induced inactivation of cytochrome P450 enzymes in rat liver microsomes"Drug Metabolism and Disposition. 26,4. 338-342 (1998)
Yasuhiro Masubuchi:“二肼苯达嗪诱导大鼠肝微粒体中细胞色素 P450 酶的失活”药物代谢和处置。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yasuhiro Masubuchi: "Possible machanism of hepatocyte injury induced by diphenylamine and its structurally related nonsteroidal anti-inflammatory drug"Journal of Pharmacology and Experimental Therapeutics. 292,3. 982-987 (2000)
Yasuhiro Masubuchi:“二苯胺及其结构相关的非甾体抗炎药诱导肝细胞损伤的可能机制”药理学和实验治疗学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K. Kumakura, M. Kitada, T. Horie and S. Awazu: "Detection of phosphatidylcholine hydroperoxide produced in the heart of the doxorubicin administered mouse."Analytical Letters. 30. 8 (1997)
K. Kumakura、M. Kitada、T. Horie 和 S. Awazu:“检测给予阿霉素的小鼠心脏中产生的磷脂酰胆碱过氧化氢。”分析快报。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yasuhiro Masubuchi, Shoko Yamada and Toshiharu Horie: "Possible mechanism of hepatocyte injury induced by diphenylamine and its structurally related nonsteroidal anti-inflammatory drug."The Journal of Pharmacology and Experimental Therapeutics. 292. 3 (20
Yasuhiro Masubuchi、Shoko Yamada 和 Toshiharu Horie:“二苯胺及其结构相关的非甾体抗炎药诱导肝细胞损伤的可能机制。”《药理学与实验治疗学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HORIE Toshiharu其他文献
HORIE Toshiharu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HORIE Toshiharu', 18)}}的其他基金
Analysis of idiosyncratic drug toxicity using mitochondria isolated from an animal model of metabolic syndrome
使用从代谢综合征动物模型中分离的线粒体分析特殊药物毒性
- 批准号:
26670084 - 财政年份:2014
- 资助金额:
$ 5.95万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Quantitative analysis of drugs induced BSEP inhibition and cholestatic hepatotoxicity
药物引起的 BSEP 抑制和胆汁淤积性肝毒性的定量分析
- 批准号:
23659073 - 财政年份:2011
- 资助金额:
$ 5.95万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Molecular analysis of localization of biliary transporters in chronic hepatitis
慢性肝炎胆汁转运蛋白定位的分子分析
- 批准号:
21249003 - 财政年份:2009
- 资助金额:
$ 5.95万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Intrahepatic imaging and molecular analysis of MRP2 localization regulated by the intracellular redox status
细胞内氧化还原状态调节的MRP2定位的肝内成像和分子分析
- 批准号:
18390012 - 财政年份:2006
- 资助金额:
$ 5.95万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
MRP2 mediated defense against oxidative stress in liver
MRP2介导的肝脏氧化应激防御
- 批准号:
16390014 - 财政年份:2004
- 资助金额:
$ 5.95万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Evaluation of drug-induced hepatotoxicity by chemiluminescence and the role of MRP2 in the hepatotoxicity
化学发光评价药物引起的肝毒性及MRP2在肝毒性中的作用
- 批准号:
13470476 - 财政年份:2001
- 资助金额:
$ 5.95万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Pharmacokinetics and Hepatotoxicity due to the oxidative stress
氧化应激引起的药代动力学和肝毒性
- 批准号:
06672155 - 财政年份:1994
- 资助金额:
$ 5.95万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
A Study on Protective Effect of Vitamin A against Antitumour Drug-Induced Damage to Small Intestine
维生素A对抗肿瘤药物所致小肠损伤的保护作用研究
- 批准号:
03671067 - 财政年份:1991
- 资助金额:
$ 5.95万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Quantitative Evaluation and Prediction of Drug-Toxicity Due to Lipid Peroxidation
脂质过氧化引起的药物毒性的定量评估和预测
- 批准号:
63571061 - 财政年份:1988
- 资助金额:
$ 5.95万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
β2-糖蛋白Ⅰ介导乙型肝炎病毒入侵肝细胞的路径研究
- 批准号:30971353
- 批准年份:2009
- 资助金额:31.0 万元
- 项目类别:面上项目
相似海外基金
Targeting Ischemia-Induced Autophagy Dependence in hepatocellular Carcinoma through Image-guided Locoregional Therapy
通过图像引导局部治疗靶向肝细胞癌中缺血诱导的自噬依赖性
- 批准号:
10585078 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:
Multicellular Organotypic Mouse Model of Alcoholic Liver Disease
酒精性肝病的多细胞器官型小鼠模型
- 批准号:
10667672 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:
Circadian and mitochondrial dysfunction in alcohol-related liver disease
酒精相关性肝病中的昼夜节律和线粒体功能障碍
- 批准号:
10667861 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:
Shifting paradigms to emerging toxins in freshwater cyanobacterial blooms
淡水蓝藻水华中新出现的毒素的范式转变
- 批准号:
10912318 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:
Mechanism-Driven Virtual Adverse Outcome Pathway Modeling for Hepatotoxicity
机制驱动的肝毒性虚拟不良结果途径建模
- 批准号:
10940417 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:
A liver-on-chip platform to evaluate panels of clinically relevant gene variants for screening of xenobiotic compounds
用于评估临床相关基因变异组以筛选异生化合物的肝脏芯片平台
- 批准号:
10738215 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:
Gene-edited liver organoids for predictive hepatotoxicity
用于预测肝毒性的基因编辑肝脏类器官
- 批准号:
10758179 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:
Mechanism-Driven Virtual Adverse Outcome Pathway Modeling for Hepatotoxicity
机制驱动的肝毒性虚拟不良结果途径建模
- 批准号:
10675944 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:
Alcohol Metabolism Disrupts Hepatic Thiol Redox Signaling and Control
酒精代谢破坏肝脏硫醇氧化还原信号和控制
- 批准号:
10585786 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:














{{item.name}}会员




